229 related articles for article (PubMed ID: 21454456)
1. Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial.
Sandison TG; Homsy J; Arinaitwe E; Wanzira H; Kakuru A; Bigira V; Kalamya J; Vora N; Kublin J; Kamya MR; Dorsey G; Tappero JW
BMJ; 2011 Mar; 342():d1617. PubMed ID: 21454456
[TBL] [Abstract][Full Text] [Related]
2. Protective efficacy of prolonged co-trimoxazole prophylaxis in HIV-exposed children up to age 4 years for the prevention of malaria in Uganda: a randomised controlled open-label trial.
Homsy J; Dorsey G; Arinaitwe E; Wanzira H; Kakuru A; Bigira V; Muhindo M; Kamya MR; Sandison TG; Tappero JW
Lancet Glob Health; 2014 Dec; 2(12):e727-36. PubMed ID: 25433628
[TBL] [Abstract][Full Text] [Related]
3. Effect of co-trimoxazole prophylaxis on morbidity and mortality of HIV-exposed, HIV-uninfected infants in South Africa: a randomised controlled, non-inferiority trial.
Daniels B; Coutsoudis A; Moodley-Govender E; Mulol H; Spooner E; Kiepiela P; Reddy S; Zako L; Ho NT; Kuhn L; Ramjee G
Lancet Glob Health; 2019 Dec; 7(12):e1717-e1727. PubMed ID: 31708152
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin-piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial.
Barsosio HC; Madanitsa M; Ondieki ED; Dodd J; Onyango ED; Otieno K; Wang D; Hill J; Mwapasa V; Phiri KS; Maleta K; Taegtmeyer M; Kariuki S; Schmiegelow C; Gutman JR; Ter Kuile FO
Lancet; 2024 Jan; 403(10424):365-378. PubMed ID: 38224710
[TBL] [Abstract][Full Text] [Related]
5. Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study.
Mermin J; Ekwaru JP; Liechty CA; Were W; Downing R; Ransom R; Weidle P; Lule J; Coutinho A; Solberg P
Lancet; 2006 Apr; 367(9518):1256-61. PubMed ID: 16631881
[TBL] [Abstract][Full Text] [Related]
6. Co-trimoxazole prophylaxis for children who are HIV-exposed and uninfected: a systematic review.
Wedderburn CJ; Evans C; Slogrove AL; Rehman AM; Gibb DM; Prendergast AJ; Penazzato M
J Int AIDS Soc; 2023 Jun; 26(6):e26079. PubMed ID: 37292018
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa.
Bwakura-Dangarembizi M; Kendall L; Bakeera-Kitaka S; Nahirya-Ntege P; Keishanyu R; Nathoo K; Spyer MJ; Kekitiinwa A; Lutaakome J; Mhute T; Kasirye P; Munderi P; Musiime V; Gibb DM; Walker AS; Prendergast AJ
N Engl J Med; 2014 Jan; 370(1):41-53. PubMed ID: 24382064
[TBL] [Abstract][Full Text] [Related]
8. Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled trial.
Lockman S; Hughes M; Powis K; Ajibola G; Bennett K; Moyo S; van Widenfelt E; Leidner J; McIntosh K; Mazhani L; Makhema J; Essex M; Shapiro R
Lancet Glob Health; 2017 May; 5(5):e491-e500. PubMed ID: 28395844
[TBL] [Abstract][Full Text] [Related]
9. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda.
Mermin J; Lule J; Ekwaru JP; Malamba S; Downing R; Ransom R; Kaharuza F; Culver D; Kizito F; Bunnell R; Kigozi A; Nakanjako D; Wafula W; Quick R
Lancet; 2004 Oct 16-22; 364(9443):1428-34. PubMed ID: 15488218
[TBL] [Abstract][Full Text] [Related]
10. Effect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance.
Gasasira AF; Kamya MR; Ochong EO; Vora N; Achan J; Charlebois E; Ruel T; Kateera F; Meya DN; Havlir D; Rosenthal PJ; Dorsey G
Malar J; 2010 Jun; 9():177. PubMed ID: 20573194
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial.
Kamya MR; Kapisi J; Bigira V; Clark TD; Kinara S; Mwangwa F; Muhindo MK; Kakuru A; Aweeka FT; Huang L; Jagannathan P; Achan J; Havlir DV; Rosenthal PJ; Dorsey G
AIDS; 2014 Nov; 28(18):2701-9. PubMed ID: 25493596
[TBL] [Abstract][Full Text] [Related]
12. Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.
Crook AM; Turkova A; Musiime V; Bwakura-Dangarembizi M; Bakeera-Kitaka S; Nahirya-Ntege P; Thomason M; Mugyenyi P; Musoke P; Kekitiinwa A; Munderi P; Nathoo K; Prendergast AJ; Walker AS; Gibb DM;
BMC Med; 2016 Mar; 14():50. PubMed ID: 27004529
[TBL] [Abstract][Full Text] [Related]
13. Randomised controlled trial testing the effect of cotrimoxazole prophylaxis on morbidity and mortality outcomes in breastfed HIV-exposed uninfected infants: study protocol.
Coutsoudis A; Daniels B; Moodley-Govender E; Ngomane N; Zako L; Spooner E; Kiepiela P; Reddy S; Kuhn L; Ramjee G
BMJ Open; 2016 Jul; 6(7):e010656. PubMed ID: 27406638
[TBL] [Abstract][Full Text] [Related]
14. Co-trimoxazole Prophylaxis, Asymptomatic Malaria Parasitemia, and Infectious Morbidity in Human Immunodeficiency Virus-Exposed, Uninfected Infants in Malawi: The BAN Study.
Davis NL; Wiener J; Juliano JJ; Adair L; Chasela CS; Kayira D; Hudgens MG; van der Horst C; Jamieson DJ; Kourtis AP; ;
Clin Infect Dis; 2017 Aug; 65(4):575-580. PubMed ID: 28444232
[TBL] [Abstract][Full Text] [Related]
15. Malaria burden in a birth cohort of HIV-exposed uninfected Ugandan infants living in a high malaria transmission setting.
Kakuru A; Natureeba P; Muhindo MK; Clark TD; Havlir DV; Cohan D; Dorsey G; Kamya MR; Ruel T
Malar J; 2016 Oct; 15(1):500. PubMed ID: 27756308
[TBL] [Abstract][Full Text] [Related]
16. Breastfeeding and the risk of malaria in children born to HIV-infected and uninfected mothers in rural Uganda.
Vora N; Homsy J; Kakuru A; Arinaitwe E; Wanzira H; Sandison TG; Bigira V; Kamya MR; Tappero JW; Dorsey G
J Acquir Immune Defic Syndr; 2010 Oct; 55(2):253-61. PubMed ID: 20683193
[TBL] [Abstract][Full Text] [Related]
17. Co-trimoxazole prophylaxis in adults, including pregnant women, with HIV: a systematic review and meta-analysis.
Suthar AB; Vitoria MA; Nagata JM; Anglaret X; Mbori-Ngacha D; Sued O; Kaplan JE; Doherty MC
Lancet HIV; 2015 Apr; 2(4):e137-50. PubMed ID: 26424674
[TBL] [Abstract][Full Text] [Related]
18. Daily co-trimoxazole prophylaxis to prevent mortality in children with complicated severe acute malnutrition: a multicentre, double-blind, randomised placebo-controlled trial.
Berkley JA; Ngari M; Thitiri J; Mwalekwa L; Timbwa M; Hamid F; Ali R; Shangala J; Mturi N; Jones KD; Alphan H; Mutai B; Bandika V; Hemed T; Awuondo K; Morpeth S; Kariuki S; Fegan G
Lancet Glob Health; 2016 Jul; 4(7):e464-73. PubMed ID: 27265353
[TBL] [Abstract][Full Text] [Related]
19. The expanding role of co-trimoxazole in developing countries.
Church JA; Fitzgerald F; Walker AS; Gibb DM; Prendergast AJ
Lancet Infect Dis; 2015 Mar; 15(3):327-39. PubMed ID: 25618179
[TBL] [Abstract][Full Text] [Related]
20. Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled study.
Kasirye RP; Baisley K; Munderi P; Levin J; Anywaine Z; Nunn A; Kamali A; Grosskurth H
AIDS; 2016 Feb; 30(4):635-44. PubMed ID: 26558729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
